Status migrainosus inpatient treatment with eptinezumab (SMITE): study protocol for a randomised controlled trial
Introduction Status migrainosus is a disabling complication of migraine, which frequently results in hospitalisation. For patients who fail to respond to simple analgesia, triptans and intravenous prochlorperazine or chlorpromazine, there are limited treatment options, and a paucity of high-quality...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2022-03-01
|
| coleção: | BMJ Open |
| Acesso em linha: | https://bmjopen.bmj.com/content/12/3/e059647.full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|